Astrea Bioseparations

What Astrea Bioseparations does

Astrea Bioseparations is a specialty chromatography and bioseparation company serving the downstream purification needs of biopharmaceutical manufacturers. Founded in 1992 and headquartered in Ballasalla, Isle of Man, with R&D operations in Cambridge, UK, additional UK presence in Gloucester, and a North American sales and operations office in Boston, the company employs 101-250 people and operates as a wholly-owned subsidiary of the Biotage group. The company designs, manufactures, and sells chromatography resins, columns, single-use capsules, and related packing services used to purify monoclonal antibodies, recombinant proteins, viral vectors, plasma-derived proteins, and other complex biologics.

The core of Astrea's offering is built on the proprietary PuraBead engineered agarose bead platform, manufactured using atomization technology, which underpins a broad portfolio spanning ion exchange, hydrophobic interaction, affinity, and mixed-mode chemistries. The AstreAdept nanofiber-based chromatography capsule line targets the cell and gene therapy market with dedicated sub-products (LentiHERO for lentivirus, ExoHERO for extracellular vesicles, pDNAHERO for plasmid DNA). Column hardware includes SNAP laboratory columns, Evolve process columns, and pre-packed EvolveD/EvolveS variants, complemented by ISO 7 cleanroom column packing services supporting 45+ commercial resins. PuraBead materials have been incorporated into multiple FDA-approved therapeutics, providing regulatory validation. Astrea also manufactures the CaptureSelect affinity ligand range on its PuraBead base matrix for Thermo Fisher Scientific under a long-standing OEM partnership.

Astrea generates revenue primarily through one-time sales of chromatography consumables and hardware (resins, columns, capsules) with quote-based enterprise pricing, supplemented by self-serve e-commerce for mid-market and academic customers with promotional incentives (10% first-order discount, up to 65% off screening kits). Professional services revenue comes from custom column packing delivered in 3-5 weeks. Distribution combines direct enterprise field sales, an owned e-commerce storefront, and a global authorized distributor network. The company's products are used across the biopharmaceutical manufacturing lifecycle, from early-stage process development through commercial GMP manufacturing, with primary end-markets including biopharma manufacturers, CDMOs/CMOs, cell and gene therapy developers, plasma protein fractionators, and academic research institutions.

Name

Astrea Bioseparations

Legal name

Astrea Bioseparations Limited

Website

https://astreabioseparations.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Short description

Astrea Bioseparations designs, manufactures, and sells chromatography resins, columns, single-use capsules, and packing services for downstream purification of monoclonal antibodies, recombinant proteins, viral vectors, plasma proteins, and cell and gene therapies used by biopharmaceutical manufacturers worldwide.

Ownership category

akta.pro rank

Product category

Bioprocessing Chromatography Products

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Downstream Processing & Purification Technologies (chromatography, filtration, centrifugation) (HLAAAJAB)

akta.pro secondary industries

Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Analytical Instruments & Chromatography Systems (HLAGAIAA)

Keywords

• Chromatography resins
• Bioprocessing products
• Bioseparation solutions
• Affinity chromatography
• Process chromatography columns

Headquarters

HQ city

Comberton

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Chromatography Resin Sales: Sale of PuraBead® chromatography resins including IEX, HIC, affinity, and mixed-mode formats for downstream purification in biopharmaceutical manufacturing.
2. Chromatography Column Sales: Sale of chromatography columns including SNAP® laboratory columns, Evolve® Process columns, and Evolve®D pre-packed columns for process development through GMP manufacturing.
3. Chromatography Capsule Sales: Sale of AstreAdept® single-use chromatography capsules including LentiHERO® for lentivirus, ExoHERO® for extracellular vesicles, and pDNAHERO® for plasmid DNA purification.
4. Column Packing Services: Custom column packing services where customers select resin and Astrea packs Evolve®D and SNAP® columns with customer's choice of media, shipped in 3-5 weeks with Certificate of Analysis.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Astrea Bioseparations manufactures and sells chromatography-based bioseparation products for downstream purification in biopharmaceutical manufacturing. Its portfolio spans proprietary PuraBead® agarose bead-based chromatography resins (IEX, HIC, affinity, mixed-mode), AstreAdept® nanofiber-based single-use chromatography capsules for cell and gene therapy, and Evolve® and SNAP® chromatography columns, supported by custom column packing services.

Product overview

Astrea Bioseparations is a Biotage company offering a comprehensive portfolio of chromatography-based bioseparation products for downstream biopharmaceutical purification. The product portfolio consists of three main product lines: (1) AstreAdept® Chromatography Capsules — a nanofiber-based platform for cell and gene therapy purification including LentiHERO® for lentivirus, ExoHERO® for extracellular vesicles, and pDNAHERO® for plasmid DNA; (2) Chromatography Columns — including SNAP® laboratory columns, Evolve® Process columns for pilot-to-production scale, Evolve®D pre-packed columns, and Column Packing Services supporting over 45 commercially available resins; and (3) PuraBead® Resins — the proprietary chromatography resin family spanning IEX (Q, SP, DEAE, CM in HF and Edge variants), HIC (Butyl, Hexyl, Octyl, Phenyl), Affinity (EtoxiClear®, AlbuPure®, MAbsorbent®, IsoClear®, Mimetic Blue®, Insulin Adsorbent, Aminophenylboronate, p-Aminobenzamidine), and Mixed-Mode Chromatography (MiMode® family including HX, HL, CBX, CX, AX variants, and BTXPure®). All PuraBead® resins are built on the proprietary PuraBead® base matrix technology. Products support applications from early-stage process development through GMP biologics manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• PuraBead®: Proprietary chromatography resin platform providing high mechanical strength, low backpressure, and scalable performance for biopharmaceutical purification
• AstreAdept®
• Evolve®
• SNAP®
• LentiHERO®
• ExoHERO®
• pDNAHERO®
• MiMode PuraBead®
• EtoxiClear®
• AlbuPure®
• MAbsorbent®
• Mimetic Blue®
• IsoClear®
• BTXPure®

Products and services

• PuraBead® Resins Chromatography resin portfolio built on the proprietary PuraBead® base matrix, including ion exchange (Q, SP, DEAE, CM in HF and Edge variants), hydrophobic interaction (Butyl, Hexyl, Octyl, Phenyl), affinity (EtoxiClear®, AlbuPure®, MAbsorbent®, Mimetic Blue®, IsoClear®, insulin and protease-specific ligands), and mixed-mode (MiMode® family plus BTXPure®) chemistries. Used in purification of monoclonal antibodies, recombinant proteins, plasma proteins, viral vectors, and advanced therapy modalities.
• AstreAdept® Chromatography Capsules

Quantifiable outcome

• Up to 99.9% endotoxin removal with EtoxiClear® while preserving protein yield
• +2 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Delta Precision LtdcoreStrategic or Co-development Partner · 9 January 2023Acquisition of Delta Precision Ltd, a manufacturer of chromatography columns for biomanufacturing. The acquisition expanded Astrea Bioseparations' product portfolio and accelerated product development in bioprocessing technologies.
• Thermo Fisher ScientificcoreOEM/ Whitelabel/ Licensing PartnerAstrea Bioseparations manufactures Thermo Fisher Scientific's CaptureSelect® affinity ligand range on their PuraBead® base matrix. This partnership has extended over a decade and supports advanced affinity purification workflows used globally in biopharmaceutical manufacturing.
• BiotagecoreOthersAstrea Bioseparations is a Biotage company, part of the Biotage group of companies. The parent company provides corporate structure and shared services including legal, HR, and data protection (privacy notices link to biotage.com).

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Cytiva: Global bioprocessing leader (formerly GE Healthcare Life Sciences) offering the broadest portfolio of chromatography resins, columns, and bioprocess consumables across mAb, vaccine, and cell/gene therapy manufacturing. Direct competitor across Astrea's resin, column, and capsule product lines.
• MilliporeSigma (Merck Life Science): Life science arm of Merck KGaA offering comprehensive bioprocessing consumables, resins, and equipment. Competes with Astrea across chromatography resins and process columns, with far broader scale and reach.
• Sartorius: Major bioprocess solutions provider offering filtration, chromatography, and fluid management. Competes across the downstream workflow including chromatography consumables, columns, and single-use systems.

Direct peers

• Tosoh Bioscience: Manufacturer of chromatography resins (TSKgel, Toyopearl) for biopharmaceutical downstream purification. Competes head-to-head with PuraBead® in IEX, HIC, and affinity formats for mAb and protein purification.
• Bio-Rad Laboratories: Manufactures chromatography resins (UNOsphere, Macro-Prep, Nuvia) and process-scale columns for biopharmaceutical purification. Directly overlaps with PuraBead® IEX, HIC, and mixed-mode offerings.
• Purolite (Ecolab Life Sciences): Manufacturer of agarose-based chromatography resins (Praesto, Jetted) for biopharmaceutical purification. Direct competitor to PuraBead® in protein A, IEX, and mixed-mode resin formats.
• Repligen: Specialized bioprocessing vendor offering chromatography resins, OPUS pre-packed columns, and single-use solutions. Direct competitor to Astrea in process columns and emerging modality purification.

Others

• Thermo Fisher Scientific: Both an OEM customer (CaptureSelect® ligands on PuraBead®) and a broader competitor through its bioproduction and chromatography portfolio (POROS, CaptureSelect). Dual relationship illustrates the ecosystem positioning around Astrea.
• Biotage: Parent company and corporate ecosystem provider. While not a direct product competitor, Biotage's strategy and capital allocation directly shape Astrea's strategic direction, product roadmap, and exit optionality.

Regional players

• Agilent Technologies: Provides analytical chromatography instruments, columns, and consumables primarily for laboratory-scale separations, with a presence in biopharma QC. Adjacent to Astrea's SNAP® laboratory column offering for process development.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/astreabio
• YouTubeyoutube.com/channel/UCTKksncAxXFg__RuS3QxLtA
• Facebookfacebook.com/AstreaBioseparations
• LinkedInlinkedin.com/company/astrea-bioseparations

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Astrea Bioseparations